-Presented by:Daniel J. Landsburg, MD who is an Associate Professor of Clinical Medicine in the Division of Hematology/Oncology at the Perelman School of Medicine of the University of Pennsylvania.

In this presentation you will learn:
-The criteria used to determine whether a stem cell transplant or CAR T-cell therapy is the best treatment option for a patient with lymphoma
-Steps involved in preparing for, undergoing and recovering from a stem cell transplant compared to CAR T-cell therapy
-Potential short and long-term side effects of a stem cell transplant compared to CAR T-cell therapy
-Likelihood of a cure and quality of life following a stem cell transplant compared to CAR T-cell therapy
-Treatment options if a patient does not achieve or remain in remission following a stem cell transplant or CAR T-cell therapy

свернуть